Events and Programs
Upcoming Live Conferences 2018 |
||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
Cardiovascular Courses
 |
Cardiology Board Review Questions and Practice Tests |  |
||||||
| SKU: | BVCAR | Format: | Board Review Prep Course | Cost: | $599.00 | |||
| Credits: | 65.0 AMA PRA Category I Credit(s)™ | |||||||
 |
Putting Emerging Lipids Data into Practice: New Treatments and Opportunities to Reduce Cardiovascular Risk | |
||||||
| SKU: | NCME342 | Format: | Monograph | Cost: | Free | |||
| Credits: | 1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|||||||
 |
Type 2 Diabetes and Cardiovascular Disease: Decreasing the Risk | |
||||||
| SKU: | NCME339 | Format: | Webcast | Cost: | Free | |||
| Credits: | 1.50 AMA PRA Category I Credit(s) ™
1.50 AANP Contact hour(s) |
|||||||
 |
Making Sense of Evolving Data to Lower CV Risk: Integrating PCSK9 Therapy into Practice | |
||||||
| SKU: | NCME340 | Format: | Webcast | Cost: | Free | |||
| Credits: | 1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) |
|||||||
 |
Recognizing Phenotypes and Evidence-Based Treatments in the Management of Heart Failure | |
||||||
| SKU: | NCME341 | Format: | Monograph | Cost: | Free | |||
| Credits: | 1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|||||||
 |
Recognizing and Managing hATTR Cardiac Amyloidosis: Bridging Evidence and Clinical Practice | |
||||||
| SKU: | NCME357 | Format: | Webcast | Cost: | Free | |||
| Credits: | 1.25 AMA PRA Category I Credit(s) ™
1.25 AANP Contact hour(s) which includes 0.25 pharmacology hour(s) |
|||||||
 |
Heart Failure: Optimizing Medical Therapy and Patient Communication | |
||||||
| SKU: | NCME364 | Format: | Monograph | Cost: | Free | |||
| Credits: | 1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|||||||
 |
Managing Lipids and Cardiovascular Risk: Using the Data to Optimize Care | |
||||||
| SKU: | NCME362 | Format: | Webcast | Cost: | Free | |||
| Credits: | 1.0 AMA PRA Category I Credit(s) ™
1.0 AANP Contact hour(s) which includes 0.75 pharmacology hour(s) |
|||||||
ABC Webcast and Monograph Enduring CME Courses (powered by NACE)
VIEW FULL CURRENT CATALOG HERE
- New Agents, New Options, and Expanded Potential In Lipid Management: Integrating The Data Into Practice
- Type 2 Diabetes and Cardiovascular Disease: Decreasing the Risk
- Making Sense of Evolving Data to Lower CV Risk: Integrating PCSK9 Therapy into Practice
- Recognizing Phenotypes and Evidence-Based Treatments in the Management of Heart Failure
- Putting Emerging Lipids Data into Practice: New Treatments and Opportunities to Reduce Cardiovascular Risk
- Treatment Resistant Hypertension: Current Status and New Innovations
- Evolving Strategies for Cardiovascular Risk Reduction: Beyond Statin Therapy
- Applying the Latest Advances and Evidence of Clinical Outcomes to Individualize Heart Failure Treatment
- Applying the Latest Advances and Evidence of Clinical Outcomes to Individualize Heart Failure Treatment: A Case Based Discussion
Clinical Challenges In Individualized Heart Failure Treatment- Lipid Management and Cardiovascular Risk Reduction: The Evolving Treatment Paradigm
- Translating the Advances in Evidence Based Medicine into Better Health Outcomes for People with Heart Failure
- Transcatheter Aortic Valve Replacement: Historical Perspectives, Current Evidence, and Future Directions
- Contemporary Management of PAD: 2015
- An Overview of OTC Drugs: History, Concerns, Expectations, and Promise
- Adherence and Utilization of Statins: Pitfalls and Promises
- More Details
2018-2024 ACCME CME Accreditation
African American Women with Familial Hypercholesterolemia
Keith C. Ferdinand, MD, FACC, FAHA, FNLA
Watch Video
- Resistant Hypertension: Incorporating Clinical Guidelines Into Practice – Posted 6 April, 2015
- Practical Strategies to Reduce HF Hospitalizations in African American Patients – Posted 6 April, 2015
- Novel Pharmacologic Advances for the Treatment of Hypercholesterolemia to Reduce LDL Levels in Patients Who Are Responsive and Refractory to Statin Therapy Feb 2, 2015, 1 PRA Credit
- Evidence Based Guideline Update: Improving Long Term Health Outcomes in Minority Populations with Acute Coronary Syndrome Feb 2, 2015, 1 PRA Credit
Announcements
- “Heart Failure in African Americans: Disparities Can Be Overcome”
- Webinar PowerPoint Slides from the Feb 27 2014 African American Women and Heart Disease Webinar
- The Amgen Scholars Program provides hundreds of undergraduate students with the opportunity to engage in a hands-on summer research experience
- GE-NMF Primary Care Leadership Program News
- View the Webcast on Evidence-Based Approaches to Treating Heart Failure in Blacks
- Participate in the CME survey on the subject of Cardiometabolic Disease in Racial and Ethnic Minorities
- View the Power Point Notes from the Teleconference Call: ICD-10 Implementation Strategies and Planning
- Read the Thank-you Letter for those that attended the first meeting of the National Program to Reduce Cardiovascular Risk Meeting Notes